Source: European Heart Journal. Conference titles: Congress of the European Society of Cardiology. Unidade: FM
Assunto: CARDIOLOGIA
ABNT
LAVITOLA, P. L. et al. Randomized study of aspirin versus warfarin for high-risk mitral rheumatic atrial fibrillation patients. European Heart Journal. London: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 17 abr. 2024. , 2002APA
Lavitola, P. L., Spina, G. S., Sampaio, R. O., Tarasoutchi, F., Nigri, M., & Grinberg, M. (2002). Randomized study of aspirin versus warfarin for high-risk mitral rheumatic atrial fibrillation patients. European Heart Journal. London: Faculdade de Medicina, Universidade de São Paulo.NLM
Lavitola PL, Spina GS, Sampaio RO, Tarasoutchi F, Nigri M, Grinberg M. Randomized study of aspirin versus warfarin for high-risk mitral rheumatic atrial fibrillation patients. European Heart Journal. 2002 ; 23( 124): 411.[citado 2024 abr. 17 ]Vancouver
Lavitola PL, Spina GS, Sampaio RO, Tarasoutchi F, Nigri M, Grinberg M. Randomized study of aspirin versus warfarin for high-risk mitral rheumatic atrial fibrillation patients. European Heart Journal. 2002 ; 23( 124): 411.[citado 2024 abr. 17 ]